Evidence map›Paper›PMID 42689596›Full record

ArticleAnalytical chemistry2026

Point-of-Care Radiation Biodosimetry via a Body-Heated Reverse Transcription-Recombinase Polymerase Amplification Coupled to a Paper-Based Vertical Flow Immunoassay.

Ashkan Khanishayan, Jerome Lacombe, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Matthew W Barrett, James Helton, Frederic Zenhausern

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ashkan KhanishayanCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.ORCID 0009-0001-4907-5252
Jerome LacombeCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.ORCID 0000-0003-0383-6332
Jasmine Pramila DevadhasanCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.
Alexander Jarrett SummersCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.ORCID 0000-0002-7372-0610
Matthew W BarrettCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.
James HeltonCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.
Frederic ZenhausernCenter for Applied NanoBioscience and Medicine, College of Medicine Phoenix, University of Arizona, 475 North Fifth Street, Phoenix, Arizona85004, United States.

Funding

Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AMUNDSON, SALLY A. · 2005 to 2024
$105.4M
Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incidentU01AI148309 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TURNER, HELEN C · 2020 to 2024
$3.2M
Targeted Biomarker Panels and Pre-processing Device for the Rapid Assessment of Radiation Injury in Easily Accessible BiofluidsU01AI148307 · NIAID · GEORGETOWN UNIVERSITY · PI LAIAKIS, EVAGELIA CHRISTOS, ZENHAUSERN, FREDERIC · 2021 to 2025
$2.9M
Self-Administrated Multiplex Radiation Indicator (SAMURAI) Kit for field triage biodosimetryU01AI189429 · NIAID · UNIVERSITY OF ARIZONA · PI Jerome Lacombe, Frederic Zenhausern · 2025 to 2026
$1.1M
Desert Mountain CARE 40779NASA NNX16A069A/SYN0003National Institute of Allergy and Infectious Diseases U01AI148307National Institute of Allergy and Infectious Diseases U01AI148309National Institute of Allergy and Infectious Diseases U01AI189429National Institute of Allergy and Infectious Diseases U19AI067773NIAID NIH HHS U01 AI148307NIAID NIH HHS U01 AI148309NIAID NIH HHS U01 AI189429NIAID NIH HHS U19 AI067773
6 · The paper itself

Abstract

Rapid biodosimetry at the point of care is critical for efficient triage and clinical management during mass-casualty radiological events. Here, we introduce a power-free biodosimetry platform integrating one-step reverse transcription recombinase polymerase amplification (RT-RPA) with vertical flow immunoassay (VFI) for the multiplex detection of two radiation-responsive transcripts (CDKN1A and DDB2) and housekeeping gene (MRPS5) from fingerstick blood. One-step RT-RPA showed optimal efficiency at 36 °C for 20 min, comparable to two-step RT-RPA and standard PCR. This temperature could be provided by the human body, where the axilla delivered a stable heat source (36.2 °C) with minimal interindividual variability across a range of environmental conditions (from 4 to 42 °C), supporting amplification comparable to thermocycler-based reactions. Amplified products were detected using a capillary-driven VFI platform. The assay demonstrated strong specificity, uniform signal distribution, and reproducibility with intra- and interassay coefficient of variation below 10% and 15%, respectively, across all three transcripts. When applied to ex vivo X-ray irradiated blood samples (1 and 2 Gy), a dose-dependent increase in CDKN1A and DDB2 signals was observed. Receiver operating characteristic analysis demonstrated that discrimination between sham- and 1 Gy-irradiated was not significant, whereas the assay distinguished sham- from 2 Gy-irradiated with area under the curve values of 0.82 (95% CI = [0.66-0.98]; p = 0.0052) and 0.89 (95% CI = [0.76-1.00]; p = 0.0006) for CDKN1A and DDB2, yielding sensitivity/specificity of 84.62%/69.23% and 92.31%/84.62%, respectively. These findings supported the feasibility of the body-heat one-step RT-RPA VFI as a rapid, equipment-free, field-deployable triage tool for large-scale radiation biodosimetry.

Indexed as

PaperPoint-of-Care SystemsRadiometryRecombinasesHumansImmunoassayRapid Diagnostic TestsReverse TranscriptionRecombinases

Identifiers

PMID42689596
PMCPMC13543845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.